FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

19338005: 2 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    32597014 Two en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442103019 2 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    2 Is a General adjectival modifier false Inferred relationship Some
    2 Is a Number false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Ethinylestradiol 5 microgram and norethisterone acetate 1 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely diphenhydramine 25 milligram and ibuprofen 200 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Ethinylestradiol 20 microgram and norethisterone acetate 1 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Hydrochlorothiazide 15 mg and methyldopa 250 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely hydrocodone bitartrate 2.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Drospirenone 2 mg and estradiol 1 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely omeprazole 40 milligram and sodium bicarbonate 1.1 gram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Pyrimethamine 25 mg and sulfadoxine 500 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Glipizide 5 mg and metformin hydrochloride 500 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Ibuprofen 400 mg and oxycodone 5 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely hydralazine hydrochloride 100 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Drospirenone 500 microgram and estradiol 1 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely hydralazine hydrochloride 50 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Furosemide 20 mg and spironolactone 50 mg oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Ethinylestradiol 20 microgram and levonorgestrel 90 microgram oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Hydrocodone bitartrate 10 mg and paracetamol 660 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Lopinavir 133.3 mg and ritonavir 33.3 mg oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Loratadine 10 mg and pseudoephedrine sulfate 240 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely ferrous fumarate 305 milligram and folic acid 350 microgram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely ferrous fumarate 322 milligram and folic acid 350 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely pethidine hydrochloride 50 milligram and promethazine hydrochloride 25 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 2 gram/1 vial powder for conventional release solution for injection Has presentation strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely cefoxitin (as cefoxitin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Some 1
    Amoxicillin (as amoxicillin sodium) 1 g and clavulanic acid (as clavulanate potassium) 200 mg powder for solution for injection vial Count of base of active ingredient False 2 Inferred relationship Some
    Aztreonam 2 g powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely benorilate 2 gram/1 sachet granules for conventional release oral suspension (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Deferoxamine mesilate 2 g powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely ampicillin (as ampicillin sodium) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely ceftazidime (as ceftazidime pentahydrate) 2 gram/1 vial powder for conventional release solution for injection Has presentation strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely ceftriaxone (as ceftriaxone sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely cefpirome (as cefpirome sulfate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Some 1
    Ifosfamide 2 g powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Dalfopristin (as dalfopristin mesilate) 350 mg and quinupristin (as quinupristin mesilate) 150 mg powder for solution for injection vial Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Codeine phosphate 60 mg and paracetamol 1 g effervescent powder for oral suspension sachet Count of base of active ingredient False 2 Inferred relationship Some
    Remifentanil (as remifentanil hydrochloride) 2 mg powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Metoclopramide hydrochloride 5 mg and paracetamol 500 mg effervescent powder for oral suspension sachet Count of base of active ingredient False 2 Inferred relationship Some
    Raltitrexed 2 mg powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely somatropin(rbe) 2 milligram/1 syringe powder for conventional release solution for injection Has presentation strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely clavulanic acid (as clavulanate potassium) 200 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Magnesium alginate 87.5 mg and sodium alginate 225 mg powder for oral suspension sachet Count of base of active ingredient False 2 Inferred relationship Some
    Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Count of base of active ingredient False 2 Inferred relationship Some
    Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial Count of base of active ingredient False 2 Inferred relationship Some
    Mitomycin 2 mg powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 2
    Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely dantron 10 milligram/1 milliliter and docusate sodium 12 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Dihydrocodeine tartrate 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Ferric ammonium citrate 16 mg/mL and folic acid 500 microgram/mL oral solution Count of base of active ingredient False 2 Inferred relationship Some
    Ferric ammonium citrate 16 mg/mL and folic acid 100 microgram/mL oral solution Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely hydroxyzine hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Orciprenaline sulfate 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Diazepam 2 mg/mL oral suspension Has concentration strength numerator value False 2 Inferred relationship Some 1
    Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amoxicillin (as amoxicillin trihydrate) 50 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 12.5 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Some
    Diphenhydramine hydrochloride 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely morphine sulfate 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely prednisolone 2 milligram/1 milliliter conventional release oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely paroxetine (as paroxetine hydrochloride) 2 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Dried aluminium hydroxide gel 44 mg/mL and magnesium hydroxide 39 mg/mL oral suspension Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely spironolactone 2 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Dried aluminium hydroxide gel 120 mg/mL and magnesium hydroxide 60 mg/mL oral suspension Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely ampicillin (as ampicillin trihydrate) 25 milligram/1 milliliter and flucloxacillin (as flucloxacillin magnesium) 25 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely methadone hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Pholcodine 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely periciazine 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely amoxicillin (as amoxicillin trihydrate) 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Some
    Dicycloverine hydrochloride 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely lopinavir 80 milligram/1 milliliter and ritonavir 20 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely phenothrin 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Midazolam (as midazolam hydrochloride) 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely sodium fluoride 2 milligram/1 gram conventional release oromucosal solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1

    Start Previous Page 6 of 24 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start